Update on Investigational Treatments for Retinal Diseases episode artwork

EPISODE · Sep 3, 2025 · 7 MIN

Update on Investigational Treatments for Retinal Diseases

from Eyewire News: The Podcast · host Eyewire News

Several companies with treatment candidates for retinal diseases provide clinical updates; Nicox releases new phase 3 data for its investigational glaucoma eye drop; the first patient is implanted with Ocumetics’ novel accommodating lens; and ASCRS provides details for its second annual Business of Refractive Cataract Surgery Summit. Learn more about your ad choices. Visit megaphone.fm/adchoices

NOW PLAYING

Update on Investigational Treatments for Retinal Diseases

0:00 7:29

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Eyewire News: The Podcast?

This episode is 7 minutes long.

When was this Eyewire News: The Podcast episode published?

This episode was published on September 3, 2025.

What is this episode about?

Several companies with treatment candidates for retinal diseases provide clinical updates; Nicox releases new phase 3 data for its investigational glaucoma eye drop; the first patient is implanted with Ocumetics’ novel accommodating lens; and ASCRS...

Can I download this Eyewire News: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!